The US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™, a recombinant chikungunya vaccine, ...
The postponement comes amid concerns that HHS Secretary Robert F. Kennedy Jr., a longtime vaccine critic, could make changes ...
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.
The main signs of COVID-19 are respiratory symptoms, like congestion and a cough. But COVID-19 can also cause skin rashes, ...
Tasha Lawson tells PEOPLE why she decided to share on TikTok about being diagnosed with cyclic vomiting syndrome and how it's affected her life.
Hypothermia occurs when we lose too much heat, too fast, and our body can’t produce enough to keep up. Risk factors include being sick, alcohol, fatigue, and open wounds.
A study on FUO in Guinea found diverse bacterial and viral infections, frequent misdiagnoses, and high antibiotic resistance, ...
In a study in Belarus and Uzbekistan, 96% of patients with drug-resistant TB who received the regimens had successful treatment outcomes.
India unveils a novel antibiotic to fight AMR and a new kala-azar drug. Experts at CSIR-CDRI Lucknow discussed CAR-T therapy and viral disease research.
Various respiratory illnesses as well as the Norovirus, otherwise known as the stomach flu, are circulating in the Chippewa Valley. “We’ve seen an increase in COVID-19, RSV, influenza, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results